Surya Constrofab Development Private Limited - Company Profile

It is a construction private limited company based in Pune, Maharashtra, India, established in 2014.
2014 Pune, Maharashtra, India Struck Off
Last Updated:
About Surya Constrofab Development Private Limited

Surya Constrofab Development Private Limited, a struck off private limited company, was established on 04 February 2014 in Pune, Maharashtra, India. Engaging in civil engineering within the construction sector, it holds CIN: U45200PN2014PTC150465. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Suvarna Kiran Khatu (Director), Usha Suryakant Khatu (Director). Past directors included Kiran Suryakant Khatu. It is based at Plot No 41, Gultekadi, Pune, Maharashtra, 411009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U45200PN2014PTC150465

  • Registration Number

    150465

  • Incorporation Date

    04 February 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 2 Months
Company report

Surya Constrofab Development Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Surya Constrofab Development Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Surya Constrofab Development Private Limited?
Current Directors
Name Designation Appointment Date Status
Suvarna Kiran Khatu Director 04 Feb 2014 Current
Usha Suryakant Khatu Director 20 Feb 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Feb 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Surya Constrofab Development.

Enhance accessibility to Surya Constrofab Development's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Surya Constrofab Development revenue growth over time
Surya Constrofab Development profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Surya Constrofab Development?

Unlock access to Surya Constrofab Development's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Surya Constrofab Development?

Surya Constrofab Development has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Surya Constrofab Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Constrofab Development's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Surya Constrofab Development
Recent Activity within the Organization
  • Director Appointment

    Progress on Usha Suryakant Khatu was appointed as a Director was appointed as a Director on 20 Feb 2016 & has been associated with this company since 10 years 2 months . was documented.

  • Director Appointment

    The activity Suvarna Kiran Khatu was appointed as a Director was appointed as a Director on 04 Feb 2014 & has been associated with this company since 12 years 2 months . was completed.

  • Company Incorporation

    Surya Constrofab Development Private Limited was registered on 04 Feb 2014 with Roc Pune & aged 12 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Surya Constrofab Development Private Limited?

The CIN of Surya Constrofab Development Private Limited is U45200PN2014PTC150465.

Where is Surya Constrofab Development Private Limited headquartered?

Surya Constrofab Development Private Limited is headquartered at Plot No 41, Gultekadi, Pune, Maharashtra, 411009.

When was Surya Constrofab Development Private Limited incorporated?

Surya Constrofab Development Private Limited was incorporated on 04 February 2014.

Who are the current directors of Surya Constrofab Development Private Limited?

The current directors of Surya Constrofab Development Private Limited are

What is the primary industry of Surya Constrofab Development Private Limited?

The primary industry of Surya Constrofab Development Private Limited is Construction.

Is Surya Constrofab Development Private Limited a listed company?

Surya Constrofab Development Private Limited is unlisted.

What is the capital structure of Surya Constrofab Development Private Limited?

The authorized capital of Surya Constrofab Development Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available